18445133|t|Concomitant degradation of beta-catenin and GSK-3 beta potently contributes to glutamate-induced neurotoxicity in rat hippocampal slice cultures.
18445133|a|Increasingly, published evidence links glutamate with the pathogenesis of Alzheimer's disease. We investigated the molecular mechanism underlying glutamate-induced neurotoxicity in hippocampus, which is primarily linked to cognitive dysfunction in Alzheimer's disease. Acute exposure of rat hippocampal slices to glutamate significantly induced cell death, as determined by media lactate dehydrogenase levels and PI staining. Moreover, this was accompanied by Ca2+ influx and calpain-1 activation, as confirmed by the proteolytic pattern of spectrin. Notably, glutamate-induced calpain-1 activation decreased the level of beta-catenin, and this process appeared to be independent of glycogen synthase kinase 3beta (GSK-3beta), since glutamate also led to loss of GSK-3beta. Calpeptin, a calpain inhibitor, attenuated the glutamate-mediated degradations of spectrin, synaptophysin, and beta-catenin except GSK-3beta and modestly increased cell survival. In contrast, the NMDA receptor antagonist 2-amino-5-phosphonopentanoic acid (APV) effectively reduced all glutamate-evoked responses, i.e., the breakdowns of spectrin, synaptophysin, beta-catenin and GSK-3beta, and cell death. Pharmacological studies and in vitro calpain-1 proteolysis confirmed that in the glutamate-treated hippocampus, calpain-1-mediated decrease of beta-catenin could occur independently of GSK-3beta and of proteasome, and that GSK-3beta degradation is independent of calpain-1. These findings together provide the first direct evidence that glutamate promotes the down-regulations of beta-catenin and GSK-3beta, which potently contribute to neurotoxicity in hippocampus during excitotoxic cell death, and a molecular basis for the protection afforded by calpeptin and APV from the neurotoxic effect of glutamate.
18445133	27	39	beta-catenin	Gene	84353
18445133	44	54	GSK-3 beta	Gene	84027
18445133	79	88	glutamate	Chemical	MESH:D018698
18445133	97	110	neurotoxicity	Disease	MESH:D020258
18445133	114	117	rat	Species	10116
18445133	185	194	glutamate	Chemical	MESH:D018698
18445133	220	239	Alzheimer's disease	Disease	MESH:D000544
18445133	292	301	glutamate	Chemical	MESH:D018698
18445133	310	323	neurotoxicity	Disease	MESH:D020258
18445133	369	390	cognitive dysfunction	Disease	MESH:D003072
18445133	394	413	Alzheimer's disease	Disease	MESH:D000544
18445133	433	436	rat	Species	10116
18445133	459	468	glutamate	Chemical	MESH:D018698
18445133	496	501	death	Disease	MESH:D003643
18445133	606	610	Ca2+	Chemical	-
18445133	622	631	calpain-1	Gene	29153
18445133	706	715	glutamate	Chemical	MESH:D018698
18445133	724	733	calpain-1	Gene	29153
18445133	768	780	beta-catenin	Gene	84353
18445133	829	859	glycogen synthase kinase 3beta	Gene	84027
18445133	861	870	GSK-3beta	Gene	84027
18445133	879	888	glutamate	Chemical	MESH:D018698
18445133	909	918	GSK-3beta	Gene	84027
18445133	920	929	Calpeptin	Chemical	MESH:C071482
18445133	967	976	glutamate	Chemical	MESH:D018698
18445133	1012	1025	synaptophysin	Gene	24804
18445133	1031	1043	beta-catenin	Gene	84353
18445133	1051	1060	GSK-3beta	Gene	84027
18445133	1141	1174	2-amino-5-phosphonopentanoic acid	Chemical	MESH:D015763
18445133	1176	1179	APV	Chemical	MESH:C095108
18445133	1205	1214	glutamate	Chemical	MESH:D018698
18445133	1267	1280	synaptophysin	Gene	24804
18445133	1282	1294	beta-catenin	Gene	84353
18445133	1299	1308	GSK-3beta	Gene	84027
18445133	1319	1324	death	Disease	MESH:D003643
18445133	1363	1372	calpain-1	Gene	29153
18445133	1407	1416	glutamate	Chemical	MESH:D018698
18445133	1438	1447	calpain-1	Gene	29153
18445133	1469	1481	beta-catenin	Gene	84353
18445133	1511	1520	GSK-3beta	Gene	84027
18445133	1549	1558	GSK-3beta	Gene	84027
18445133	1589	1598	calpain-1	Gene	29153
18445133	1663	1672	glutamate	Chemical	MESH:D018698
18445133	1706	1718	beta-catenin	Gene	84353
18445133	1723	1732	GSK-3beta	Gene	84027
18445133	1763	1776	neurotoxicity	Disease	MESH:D020258
18445133	1799	1810	excitotoxic	Disease	
18445133	1816	1821	death	Disease	MESH:D003643
18445133	1876	1885	calpeptin	Chemical	MESH:C071482
18445133	1890	1893	APV	Chemical	MESH:C095108
18445133	1903	1913	neurotoxic	Disease	MESH:D020258
18445133	1924	1933	glutamate	Chemical	MESH:D018698
18445133	Negative_Correlation	MESH:D015763	84027
18445133	Association	MESH:D020258	84027
18445133	Negative_Correlation	MESH:C071482	MESH:D020258
18445133	Positive_Correlation	MESH:D018698	MESH:D000544
18445133	Negative_Correlation	MESH:C095108	MESH:D003643
18445133	Negative_Correlation	29153	84353
18445133	Positive_Correlation	MESH:D018698	MESH:D020258
18445133	Negative_Correlation	MESH:C095108	24804
18445133	Negative_Correlation	MESH:C095108	MESH:D018698
18445133	Negative_Correlation	MESH:C095108	MESH:D020258
18445133	Association	MESH:D018698	84027
18445133	Positive_Correlation	MESH:D018698	MESH:D003643
18445133	Association	MESH:D020258	84353
18445133	Negative_Correlation	MESH:C095108	84027
18445133	Negative_Correlation	MESH:C071482	24804
18445133	Association	MESH:D003643	84027
18445133	Negative_Correlation	MESH:C071482	MESH:D018698
18445133	Negative_Correlation	MESH:D015763	MESH:D003643
18445133	Association	84027	84353
18445133	Negative_Correlation	MESH:C095108	84353
18445133	Association	MESH:D003643	84353
18445133	Negative_Correlation	MESH:D018698	84353
18445133	Positive_Correlation	MESH:D018698	MESH:D003072
18445133	Positive_Correlation	MESH:D018698	29153
18445133	Negative_Correlation	MESH:D015763	24804
18445133	Negative_Correlation	MESH:D015763	MESH:D018698
18445133	Negative_Correlation	MESH:D018698	24804
18445133	Negative_Correlation	MESH:C071482	84353
18445133	Negative_Correlation	MESH:D015763	84353

